US Nuclear (UCLE) AI Stock Analysis

• Market Cap: $5.83M
• Dividend Yield: N/A
• Average Volume (3M): 281.28K
• Price to Earnings (P/E): ―
• Beta (1Y): -15.70
• Revenue Growth: -16.18%
• EPS Growth: 35.81%
• Country: US
• Employees: 8
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): N/A
• Shares Outstanding: 61,382,263
• 10 Day Avg. Volume: 117,656
• 30 Day Avg. Volume: 281,279
• PEG Ratio: 0.04
• Price to Book (P/B): -4.31
• Price to Sales (P/S): 1.69
• P/FCF Ratio: -7.26
• Enterprise Value/Market Cap: 1.12
• Enterprise Value/Revenue: 3.31
• Enterprise Value/Gross Profit: 7.86
• Enterprise Value/Ebitda: -4.51
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: $0.10 ▼(-24.62% Downside)

The score is primarily weighed down by weak financial performance (sharp TTM revenue decline, persistent losses, negative operating/free cash flow, and high leverage with a history of negative equity). Technicals provide a partial offset with the stock trading above major moving averages and positive MACD, but valuation remains unattractive due to ongoing losses and no dividend support.

Positive Factors

Niche leader in radiation detection

Operating in a specialized, safety-critical niche creates durable demand from nuclear, government and commercial customers. Long sales cycles and regulatory requirements make switching costly, supporting sustained revenue opportunities for core detection and monitoring products.

Recurring services and government partnerships

Maintenance contracts, support services and government partnerships create recurring, contractable revenue and potential R&D funding. These structural revenue sources smooth cycles, increase customer stickiness, and support long-term product development and tailored solutions.

Moderate gross profit margin base

A moderate gross margin provides a structural foundation to reach profitability if revenue stabilizes or scales. With cost control and higher utilization of installed base services, the company could leverage existing margin profile into positive operating leverage over the medium term.

Negative Factors

Negative stockholders' equity

Negative equity signals an impaired balance sheet and effectively infinite debt-to-equity, limiting financial flexibility. This structural capital shortfall raises dilution or restructuring risk, increases borrowing costs and constrains the firm’s ability to fund growth or endure shocks.

Persistent negative free cash flow

Ongoing negative free cash flow and reliance on financing are structural weaknesses that erode liquidity and force external funding. Over months, this limits capacity for R&D, capital improvements, and contract fulfilment, and increases execution risk and potential dilution.

Consistent net losses and declining revenue

Sustained net losses and recent revenue decline undermine internal funding for operations and innovation. Without durable revenue recovery or margin improvement, losses will continue to deplete resources, making long-term competitiveness and investment in product development more difficult.

US Nuclear Business Overview & Revenue Model

Company Description

US Nuclear Corporation (UCLE) is a leading provider of radiation detection and monitoring systems, specializing in advanced technologies for nuclear safety and environmental monitoring. The company operates primarily in the nuclear industry, offering a range of products and services that include radiation detection equipment, radiation monitoring systems, and environmental assessment solutions. UCLE focuses on innovations that enhance the safety and efficiency of nuclear operations, catering to both government and commercial sectors.

How the Company Makes Money

US Nuclear generates revenue through the sale of its radiation detection and monitoring products, which are essential for ensuring safety in nuclear facilities and other industries that require radiation monitoring. Key revenue streams include direct sales of specialized equipment, ongoing maintenance and support services, and potential licensing agreements for its proprietary technologies. The company also benefits from partnerships with governmental agencies and educational institutions, which provide funding for research and development projects, further contributing to its financial growth.

US Nuclear Financial Statement Overview

Summary

Fundamentals are very weak: TTM revenue fell sharply (~78%), operating and net margins remain deeply negative, and operating/free cash flow are consistently negative. The balance sheet is high risk with very high leverage (~5.2x debt-to-equity) and prior periods of negative equity, indicating reliance on external financing despite some moderation in cash burn.

Income Statement

UCLE’s Income Statement profile remains weak. Revenue in TTM (Trailing-Twelve-Months) declined sharply (down ~78% vs. prior period), following relatively flat-to-down performance in recent annual periods. While gross margin has been moderate (roughly low-40% range in recent years), operating results are deeply negative, with operating losses close to the size of revenue in TTM (Trailing-Twelve-Months) and net margin still heavily negative. The key strength is that gross profit remains positive (the core product economics are not fully broken), but the company’s cost structure is not scaling to its revenue base, keeping profitability meaningfully challenged.

Balance Sheet

The Balance Sheet shows elevated financial risk and volatility. Leverage is high in TTM (Trailing-Twelve-Months) with debt running at ~5.2x equity, implying limited balance-sheet flexibility. Equity has also been negative in multiple annual periods (2022–2024), a major red flag for creditor and funding risk, even though it turns modestly positive in TTM (Trailing-Twelve-Months). Total assets have been relatively stable, but the capital structure has been unstable over time. Overall, the company appears dependent on maintaining access to financing while it works toward operating improvement.

Cash Flow

Cash Flow quality is weak, with operating cash flow negative across all shown periods, including TTM (Trailing-Twelve-Months). Free cash flow is also consistently negative, indicating the business is not self-funding. A relative positive is that cash burn appears lower in TTM (Trailing-Twelve-Months) than some prior annual periods (less negative than 2022–2024), but it remains a burn profile rather than a generation profile. With losses continuing and cash flow still negative, liquidity durability likely depends on external capital.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.97M	2.19M	2.23M	2.09M	2.14M	1.75M
Gross Profit	828.26K	1.02M	924.31K	788.07K	1.38M	474.51K
EBITDA	-1.44M	-1.51M	-1.78M	-1.49M	-1.81M	-2.87M
Net Income	-1.63M	-1.74M	-3.43M	-2.04M	-1.88M	-3.54M
Balance Sheet
Total Assets	2.54M	2.65M	2.86M	3.11M	2.85M	2.45M
Cash, Cash Equivalents and Short-Term Investments	75.91K	130.84K	152.84K	126.11K	246.32K	227.30K
Total Debt	758.53K	1.78M	2.24M	1.60M	910.27K	825.48K
Total Liabilities	155.17K	3.50M	4.84M	3.46M	2.41M	1.61M
Stockholders Equity	146.39K	-856.16K	-1.98M	-348.30K	441.27K	847.16K
Cash Flow
Free Cash Flow	-179.56K	-509.05K	-264.30K	-1.32M	-447.47K	-614.15K
Operating Cash Flow	-179.56K	-509.05K	-263.44K	-1.32M	-441.03K	-614.15K
Investing Cash Flow	-9.19K	-30.77K	-24.55K	0.00	-21.45K	-235.00K
Financing Cash Flow	232.88K	517.82K	314.72K	1.20M	481.49K	-11.21K

US Nuclear Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.13
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UCLE, the sentiment is Positive. The current price of 0.13 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.07, and above the 200-day MA of 0.05, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.78 is Neutral, neither overbought nor oversold. The STOCH value of 85.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UCLE.

US Nuclear Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MIND	66 Neutral	$79.08M	22.80	9.37%	―	2.21%	-15.60%
CPSH	64 Neutral	$96.01M	-131.53	-3.84%	―	38.22%	70.68%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
LGL	58 Neutral	$39.99M	44.19	2.33%	―	14.07%	153.24%
NEON	56 Neutral	$30.38M	3.38	38.72%	―	-48.54%	―
UCLE	46 Neutral	$5.83M	-2.53	―	―	-16.18%	35.81%